Transmission of Mother-Infant Stress Communication
MIBLS
Transmission of Discrimination-Related Stress Reactivity and Reduction From Mother to Infant
1 other identifier
observational
56
1 country
2
Brief Summary
The central aim of this study is to assess mother-infant communication via behavioral, physiological, and affective indices under conditions where distal stressors may not be directly detectable by the infant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2013
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 11, 2013
CompletedFirst Posted
Study publicly available on registry
December 17, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 14, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 14, 2016
CompletedOctober 18, 2018
October 1, 2018
2.8 years
December 11, 2013
October 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Salivary Cortisol
Salivary cortisol is a measure that indicates hypothalamus-pituitary-adrenal axis activity. The study obtains 4 assessments with 20 minutes between each assessment. Participants chew on a cotton role for 2-minutes which is placed in a cortisol salivette tube (Sarstedt)
One lab appointment for approximately 80 minutes.
Secondary Outcomes (1)
Salivary Amylase
One lab appointment for approximately 80 minutes.
Other Outcomes (1)
Mother-infant observations
One lab appointment for approximately 80 minutes.
Eligibility Criteria
Community sample of women (ages 18-40) with infants ages 4-9 months
You may qualify if:
- Healthy volunteers
You may not qualify if:
- No presence of heart murmur or wear a pacemaker
- No medication for hypertensive or cardiovascular disease
- Not using beta blockers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Mass. Boston
Boston, Massachusetts, 02125, United States
University of Massachusetts, Boston, Child Development Unit
Boston, Massachusetts, 02125, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kymberlee O'Brien, PhD
Postdoctoral Research Fellow
- STUDY DIRECTOR
Celia L Moore, PhD
Director of DSRC and Horizon Center
- STUDY DIRECTOR
Edward Tronick, PhD
Director Child Development Unit
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 11, 2013
First Posted
December 17, 2013
Study Start
October 1, 2013
Primary Completion
July 14, 2016
Study Completion
July 14, 2016
Last Updated
October 18, 2018
Record last verified: 2018-10